** Shares in Bavarian Nordic BAVA.CO fall 6.4% to their lowest level since July, after the Danish vaccine maker narrows its 2025 revenue outlook
** The group now sees 2025 revenue of DKK 6 billion ($937.08 million), at the lower end of its previously guided range of DKK 6-6.6 billion
** Kempen says the group narrows its outlook as it is not expecting further contract deliveries in 2025
** "With the private equity bid falling through, we now see it crucial that Bavarian Nordic delivers on pipeline milestones and contracts to justify its valuation and places company at a strategic inflection point," Kempen adds
** The takeover offer for Bavarian fell through last week
** The stock is at the bottom of STOXX 600 index .STOXX
($1 = 6.4029 Danish crowns)
(Reporting by Jagoda Darlak)
((Jagoda.Darlak@thomsonreuters.com; +48 58 769 65 40;))